PCRX Insider Trading Activity and SEC Form 4 Filings
Trump's trades in PCRX
From his financial disclosures
$15K+
1 purchase
-
0 sales
Purchase
Jan 30, 2026
Reported 104d later
$15K - $50K
Many orders in these accounts are placed by the account manager.
PCRX insider trading summary
Over the past 12 months, insiders at Pacira BioSciences, Inc. (PCRX) reported 12 sales worth $2.0M by 4 insiders and no open-market purchases on SEC Form 4. Net insider selling was $2.0M.
Latest PCRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 8, 2026 | Lauren Riker | Senior Vice President, Finance | Sell | $218K (6,000 @ $36.32) |
| Jun 11, 2026 | Lauren Riker | Senior Vice President, Finance | Sell | $144K (6,115 @ $23.50) |
| Apr 22, 2026 | Shawn Cross | Chief Financial Officer | Sell | $38K (1,500 @ $25.01) |
| Apr 21, 2026 | Shawn Cross | Chief Financial Officer | Sell | $71K (2,845 @ $25.01) |
| Apr 20, 2026 | Shawn Cross | Chief Financial Officer | Sell | $194K (7,714 @ $25.14) |
| Feb 2, 2026 | Kristen Williams | Chief Administrative Officer | Sell | $270K (13,137 @ $20.53) |
| Feb 2, 2026 | Lauren Riker | Senior Vice President, Finance | Sell | $83K (4,000 @ $20.81) |
| Jan 5, 2026 | Lauren Riker | Senior Vice President, Finance | Sell | $34K (1,416 @ $24.24) |
| Dec 10, 2025 | Shawn Cross | Chief Financial Officer | Sell | $229K (9,104 @ $25.14) |
| Dec 9, 2025 | Shawn Cross | Chief Financial Officer | Sell | $398K (15,896 @ $25.03) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.